42 Results for "

ADAM17

" in MedChemExpress (MCE) Product Catalog:
Products (42)

42 Results for "ADAM17" in MCE Product Catalog:

  • Isoforms Recommended:
Cat. No.: HY-RS00271
Research Areas:  

Others

ADAM17 Human Pre-designed siRNA Set A contains three designed siRNAs for ADAM17 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-172394
ZSNI-21 is a ADAM17/HDAC2 inhibitor with ADAM17 IC50 0.939 μM and HDAC2 IC50 0.844 μM. ZSNI-21 regulates the expression of apoptosis-related proteins (Bax, Bcl-2) and Cyclin D1, and induces apoptosis.. ZSNI-21 can be used for the research of hepatocellular carcinoma, breast cancer, and non-small cell lung cancer .
loading...
    loading...
Cat. No.: HY-P10174
Target:  

Fluorescent Dye MMP

Research Areas:  

Others

ADAM-17 Substrate is a fluorescent substrate of ADAM .
loading...
    loading...
Cat. No.: HY-RS00272
Research Areas:  

Others

Adam17 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Adam17 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS00273
Research Areas:  

Others

Adam17 Rat Pre-designed siRNA Set A contains three designed siRNAs for Adam17 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-101984R
CAS No.: 2620-62-4
N6,N6-Dimethyladenosine (Standard) is the analytical standard of N6,N6-Dimethyladenosine (HY-101984). This product is intended for research and analytical applications. N6,N6-Dimethyladenosine, a modified ribonucleoside, is an endogenous A3 adenosine receptor ligand. N6,N6-Dimethyladenosine is an AKT inhibitor with antitumor effects. N6, N6-Dimethyladenosine targets SARS-CoV-2 entry protein ADAM17. N6, N6-Dimethyladenosine robustly inhibits AKT signaling in a variety of non-small cell lung cancer cell lines.
loading...
    loading...
Cat. No.: HY-110397G
CAS No.: 1365803-52-6
KP-457 (GMP) is KP-457 (HY-110397) produced by using GMP guidelines. GMP small molecules work appropriately as an auxiliary reagent for cell therapy manufacture.KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively .
loading...
    loading...
Cat. No.: HY-P992185

Target:  

MMP

Research Areas:  

Inflammation/Immunology

Anti-ADAM17 Antibody is a monoclonal antibody targeting ADAM17. It can be used in ELISA, FACS, and functional assays. For isotype controls of Anti-ADAM17 Antibody, please refer to Human IgG1 kappa, Isotype Control (HY-P99001).
loading...
    loading...
Cat. No.: HY-P84440
Synonyms: ADAM17; CSVP; TACE; NISBD; ADAM18; ; NISBD1

Host:  

Mouse

Application:  

WB, ICC/IF, FC, ELISA

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P84440A
Synonyms: ADAM17; CSVP; TACE; NISBD; ADAM18; ; NISBD1

Host:  

Mouse

Application:  

WB, ICC/IF, FC, ELISA

Reactivity:  

Human, Mouse

loading...
    loading...
Cat. No.: HY-P81817
Synonyms: CD156b; ADAM17; CSVP; TACE

Host:  

Rabbit

Application:  

WB, ICC/IF, IP, FC

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-W703549
Synonyms: INCB007839-d3; INCB7839-d3
Aderbasib-d3 (INCB007839-d3) is deuterium labeled Aderbasib. Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2 +?breast cancer, gliomas, et al .
loading...
    loading...
Cat. No.: HY-P992406

Target:  

MMP IFNAR

Research Areas:  

Cancer

MEDI-3622 is a human monoclonal antibody against ADAM17. MEDI-3622 blocks the ADAM17-mediated shedding of CD16A and CD62L on NK cells, and binds with high specificity to a surface loop unique to the metalloprotease catalytic domain of ADAM17. MEDI-3622 enhances IFNγ production by NK cells when they bind to antibody-coated tumor cells. MEDI-3622 can be used in the research of ovarian cancer, Burkitt lymphoma, head and neck cancer, and colorectal cancer .
loading...
    loading...
Cat. No.: HY-165060
CAS No.: 848667-56-1
Synonyms: (±)2-14,15-EG
Target:  

DNA/RNA Synthesis

Research Areas:  

Metabolic Disease

(±)2-(14,15-Epoxyeicosatrienoyl) glycerol ((±)2-14,15-EG) is a novel CYP450 metabolite of 2-Arachidonoyl glycerol (2-AG) in the kidney. (±)2-(14,15-Epoxyeicosatrienoyl) glycerol is a potent mitogen for renal epithelial cells, increasing DNA synthesis in LLCPKcl4 cells. (±)2-(14,15-Epoxyeicosatrienoyl) glycerol activates the metalloprotease ADAM17, which cleaves proTGF-α and releases TGF-α as a ligand that initiates the EGFR-ERK signalling pathway .
loading...
    loading...
Cat. No.: HY-115670R
CAS No.: 866924-39-2
Target:  

Reference Standards MMP

Research Areas:  

Inflammation/Immunology Cancer

GW280264X (Standard) is the analytical standard of GW280264X (HY-115670). This product is intended for research and analytical applications. GW280264X is the mixed ADAM10/TACE (ADAM17) metalloproteinases inhibitor. GW280264X potently blocks TACE (ADAM17) and ADAM10 with IC50s of 8.0 nM and 11.5 nM, respectively . ADAM10 and 17 modulate the immunogenicity of glioblastoma-initiating cells .
loading...
    loading...
Cat. No.: HY-P702499
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: ADAM17; Snake Venom-Like Protease; Prev. TACE; ADAM Metallopeptidase Domain 18; CSVP; Uncharacterized Protein ADAM17; Disintegrin And Metalloproteinase Domain-Containing Protein 17; TNF-Alpha Converting Enzyme; TNF-Alpha Convertase; CD156b Antigen; CD156B; ADAM17 Protein; Tumor Necrosis Factor, Alpha, Converting Enzyme; ADAM 17; A Disintegrin And Metalloproteinase 17; HYPT16; Cartilage Snake Venom-Like Protease; NISBD1; TNF-Alpha Convertase Enzyme; NISBD; TNF-Alpha-Converting Enzyme; ADAM Metallopeptidase Domain 17; ADAM18
Species:  
Human
Source:  
CHO
loading...
    loading...
Cat. No.: HY-110397R
CAS No.: 1365803-52-6
Target:  

Reference Standards MMP

Research Areas:  

Cardiovascular Disease

KP-457 (Standard) is the analytical standard of KP-457 (HY-110397). This product is intended for research and analytical applications. KP-457 is a selective a disintegrin and metalloproteinase 17 (ADAM17) inhibitor, with higher selectivity for ADAM17 than for other MMPs and ADAM10, and IC50s are 11.1 nM (ADAM17), 748 nM (ADAM10), 717 nM (MMP2), 9760 nM (MMP3), 2200 nM (MMP8), 5410 nM (MMP9), 930 nM (MMP13), 2140 nM (MMP14), and 7100 nM (MMP17), respectively.
loading...
    loading...
Cat. No.: HY-P992341

Target:  

MMP

Research Areas:  

Cancer

D8P1C1 is a high-affinity ADAM17 inhibitor (with a Kd of 180 pM targeting ADAM17-ECD) that reduces the shedding and phosphorylation of EGFR ligands. D8P1C1 inhibits cancer cell proliferation in vitro and tumor growth in xenograft models. 89Zr-DFO-D8P1C1 radioimmunological PET imaging shows its substantial accumulation in ovarian tumor xenografts, serving as a platform for generating bispecific T-cell engager derivatives. D8P1C1 can be applied to research on related diseases including triple-negative breast cancer, various types of ovarian cancer, lung adenocarcinoma, glioma, and colon cancer .
loading...
    loading...
Cat. No.: HY-10293R
CAS No.: 791828-58-5
Synonyms: INCB007839 (Standard); INCB7839 (Standard)
Target:  

Reference Standards MMP

Research Areas:  

Cancer

Aderbasib (Standard) is the analytical standard of Aderbasib (HY-10293). This product is intended for research and analytical applications. Aderbasib (INCB007839) is a potent, orally active and target specific low nanomolar hydroxamate-based inhibitor of ADAM10 and ADAM17. Aderbasib exhibits robust antineoplastic activity and can be used for cancer research, including diffuse large B-cell non-Hodgkin lymphoma, HER2+ breast cancer, gliomas, et al .
loading...
    loading...
Cat. No.: HY-137839
CAS No.: 927827-98-3
Target:  

MMP

Research Areas:  

Inflammation/Immunology

Anti-inflammatory agent 121 is a protease inhibitor, with IC50 values against different targets as follows: 1.3 μM (Staphylococcus aureus type I staphylokinase), 2.2 μM (Staphylococcus aureus type II staphylokinase), 2.3 μM (human MMP-1), 2.7 μM (human MMP-2), 1.4 μM (human MMP-8), 4.6 μM (human MMP-9), and 79 μM (human ADAM17). Anti-inflammatory agent 121 inhibits the activities of staphylococcal serine protease glutamyl endopeptidase (V8 protease) and cysteine protease staphylococcal protease B in Staphylococcus aureus cultures. Anti-inflammatory agent 121 inhibits protease activity in skin wash samples, metalloprotease (staphylokinase) activity in Staphylococcus aureus culture supernatants, and staphylokinase-mediated activation of pro-urokinase-type plasminogen activator (pro-uPA). Anti-inflammatory agent 121 can be used in the research of atopic dermatitis .
loading...
    loading...